Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) FCF Margin: 2009-2024

Historic FCF Margin for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to 4.94%.

  • OptimizeRx's FCF Margin rose 42300.0% to 12.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.62%, marking a year-over-year increase of 117800.0%. This contributed to the annual value of 4.94% for FY2024, which is 161600.0% up from last year.
  • Per OptimizeRx's latest filing, its FCF Margin stood at 4.94% for FY2024, which was up 161600.0% from 11.22% recorded in FY2023.
  • OptimizeRx's FCF Margin's 5-year high stood at 16.8% during FY2022, with a 5-year trough of 14.73% in FY2020.
  • Moreover, its 5-year median value for FCF Margin was 0.59% (2021), whereas its average is 0.72%.
  • Per our database at Business Quant, OptimizeRx's FCF Margin skyrocketed by 162100bps in 2022 and then tumbled by -280200bps in 2023.
  • OptimizeRx's FCF Margin (Annual) stood at 14.73% in 2020, then surged by 104bps to 0.59% in 2021, then skyrocketed by 2745bps to 16.8% in 2022, then crashed by -167bps to 11.22% in 2023, then soared by 144bps to 4.94% in 2024.
  • Its FCF Margin was 4.94% in FY2024, compared to 11.22% in FY2023 and 16.8% in FY2022.